AI-Assisted Relaxation and Breathing Training in Postmenopausal Women
NCT ID: NCT07302750
Last Updated: 2025-12-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
48 participants
INTERVENTIONAL
2026-01-31
2027-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this three-arm randomized controlled trial, participants will be assigned to physiotherapist-led relaxation and breathing training, AI-assisted relaxation and breathing training, or a control group. Interventions will last eight weeks and include sessions three days per week, each approximately 30 minutes. The physiotherapist-guided group will perform sessions face-to-face, while the AI-assisted group will complete prerecorded relaxation and breathing exercises created with AI-generated scripts and voice recordings. The control group will continue daily routines without structured training during the study period.
Assessments will be conducted at baseline and at the end of eight weeks. Outcome measures will include pain severity, pressure pain threshold, musculoskeletal symptoms, menopause-specific quality of life, psychological status, sleep quality, dyspnea, and participant satisfaction. The study aims to compare the effects of physiotherapist-led and AI-assisted training modalities on pain, musculoskeletal health, sleep, psychological well-being, and quality of life. Findings are expected to contribute to the development of accessible and cost-effective interventions that support symptom management and improve the daily functioning of postmenopausal women.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Physiotherapist-Guided Relaxation and Breathing Training
Participants will receive individual face-to-face relaxation and breathing training supervised by a physiotherapist.
Physiotherapist-Guided Relaxation and Breathing Training
Participants will perform the sessions individually and face-to-face under the supervision of a physiotherapist. Relaxation positions and breathing exercises will be guided and monitored by the physiotherapist. The training will be conducted three days a week for eight weeks, with each session lasting approximately 30 minutes.
Artificial Intelligence-Assisted Relaxation and Breathing Training
Participants will follow an AI-generated relaxation and breathing training program.
Artificial Intelligence-Assisted Relaxation and Breathing Training
In this group, a 30-minute relaxation and breathing training script will be created by the researchers based on instructional prompts provided to the artificial intelligence system. The generated script will be reviewed and finalized by the researchers and then converted into an audio file using an AI-based voice generation program. Participants will listen to these audio recordings asynchronously via smartphone or tablet, three days a week for eight weeks, with each session lasting approximately 30 minutes. They will also be asked to keep a daily practice log.
Control Group
Participants receive general information about relaxation and breathing exercises but do not participate in a structured program during the eight-week study period.
Control Group - No Structured Training Program
Participants will be informed about relaxation and breathing exercises. After the initial assessments, they will be asked to continue their daily routines and not to participate in any structured exercise training program for eight weeks. After the intervention period, participants in the control group will be invited to join one of the training groups if they wish.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physiotherapist-Guided Relaxation and Breathing Training
Participants will perform the sessions individually and face-to-face under the supervision of a physiotherapist. Relaxation positions and breathing exercises will be guided and monitored by the physiotherapist. The training will be conducted three days a week for eight weeks, with each session lasting approximately 30 minutes.
Artificial Intelligence-Assisted Relaxation and Breathing Training
In this group, a 30-minute relaxation and breathing training script will be created by the researchers based on instructional prompts provided to the artificial intelligence system. The generated script will be reviewed and finalized by the researchers and then converted into an audio file using an AI-based voice generation program. Participants will listen to these audio recordings asynchronously via smartphone or tablet, three days a week for eight weeks, with each session lasting approximately 30 minutes. They will also be asked to keep a daily practice log.
Control Group - No Structured Training Program
Participants will be informed about relaxation and breathing exercises. After the initial assessments, they will be asked to continue their daily routines and not to participate in any structured exercise training program for eight weeks. After the intervention period, participants in the control group will be invited to join one of the training groups if they wish.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being in natural menopause (no menstrual bleeding for at least 12 months)
* Having non-specific chronic musculoskeletal pain for at least 3 months (reporting a pain intensity of at least 4 cm on the VAS)
* Using only standard analgesic medications for pain management
* Being literate
* Owning a smartphone or tablet, having the ability to listen to audio recordings, and having adequate skills to participate in online sessions
* Being willing to participate in the study and providing written informed consent
Exclusion Criteria
* Regular use of opioid analgesics, anticonvulsants, antidepressants, or similar medications
* Uncontrolled advanced cardiovascular, oncological, metabolic, rheumatologic, or neurological diseases
* Body Mass Index (BMI) of 40 kg/m² or higher
* History of major surgery or severe trauma within the past 3 months
45 Years
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Baskent University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Neslihan Duruturk
Prof. Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Neslihan Durutürk, Prof. Dr.
Role: STUDY_DIRECTOR
Başkent University, Faculty of Health Sciences, Department of Physical Therapy and Rehabilitation
Aslıcan Çağlar, Asst. Prof.
Role: PRINCIPAL_INVESTIGATOR
Başkent University, Faculty of Health Sciences, Department of Physical Therapy and Rehabilitation
Şeyma Mutlu Kayaarslan, MSc.
Role: PRINCIPAL_INVESTIGATOR
Başkent University, Faculty of Health Sciences, Department of Physical Therapy and Rehabilitation
Hilal Yazici İlhan, MSc.
Role: PRINCIPAL_INVESTIGATOR
Başkent University, Faculty of Health Sciences, Department of Physical Therapy and Rehabilitation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Baskent University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Cardiopulmonary Rehabilitation Unit
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Hilditch JR, Lewis J, Peter A, van Maris B, Ross A, Franssen E, Guyatt GH, Norton PG, Dunn E. A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas. 1996 Jul;24(3):161-75. doi: 10.1016/s0378-5122(96)82006-8.
Alaca N, Safran EE, Karamanlargil AI, Timucin E. Translation and cross-cultural adaptation of the extended version of the Nordic musculoskeletal questionnaire into Turkish. J Musculoskelet Neuronal Interact. 2019 Dec 1;19(4):472-481.
Price DD, McGrath PA, Rafii A, Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain. 1983 Sep;17(1):45-56. doi: 10.1016/0304-3959(83)90126-4.
Garg R, Munshi A. Revolutionizing Menopause Management: Harnessing the Potential of Artificial Intelligence. J Midlife Health. 2024 Apr-Jun;15(2):53-54. doi: 10.4103/jmh.jmh_104_24. Epub 2024 Jul 5. No abstract available.
Ağargün et al. Turkish PSQI validity. Turkish Journal of Psychiatry. 1996;7:107-115.
Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213. doi: 10.1016/0165-1781(89)90047-4.
Cotes JE. Medical Research Council Questionnaire on Respiratory Symptoms (1986). Lancet. 1987 Oct 31;2(8566):1028. doi: 10.1016/s0140-6736(87)92593-1. No abstract available.
Aydemir O. Turkish validation of HADS. Turkish Journal of Psychiatry. 1997;8:187-280.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x.
Turhan E, Inandi T. Assessment of reliability and validity of the Menopause-Specific Quality of Life Questionnaire in a Turkish population. HealthMED. 2011;5:111.
Rughani G, Nilsen TIL, Wood K, Mair FS, Hartvigsen J, Mork PJ, Nicholl BI. The selfBACK artificial intelligence-based smartphone app can improve low back pain outcome even in patients with high levels of depression or stress. Eur J Pain. 2023 May;27(5):568-579. doi: 10.1002/ejp.2080. Epub 2023 Jan 27.
Vambheim SM, Kyllo TM, Hegland S, Bystad M. Relaxation techniques as an intervention for chronic pain: A systematic review of randomized controlled trials. Heliyon. 2021 Aug 20;7(8):e07837. doi: 10.1016/j.heliyon.2021.e07837. eCollection 2021 Aug.
Doorley J, Greenberg J, Stauder M, Vranceanu AM. The role of mindfulness and relaxation in improved sleep quality following a mind-body and activity program for chronic pain. Mindfulness (N Y). 2021 Nov;12(11):2672-2680. doi: 10.1007/s12671-021-01729-y. Epub 2021 Sep 1.
Ong JC, Manber R, Segal Z, Xia Y, Shapiro S, Wyatt JK. A randomized controlled trial of mindfulness meditation for chronic insomnia. Sleep. 2014 Sep 1;37(9):1553-63. doi: 10.5665/sleep.4010.
Dunford E, DClinPsy MT. Relaxation and Mindfulness in Pain: A Review. Rev Pain. 2010 Mar;4(1):18-22. doi: 10.1177/204946371000400105.
Saensak S, Vutyavanich T, Somboonporn W, Srisurapanont M. Relaxation for perimenopausal and postmenopausal symptoms. Cochrane Database Syst Rev. 2014 Jul 20;2014(7):CD008582. doi: 10.1002/14651858.CD008582.pub2.
Amin SM, El-Gazar HE, Zoromba MA, El-Sayed MM, Awad AGE, Atta MHR. Mindfulness for Menopausal Women: Enhancing Quality of Life and Psychological Well-Being Through a Randomized Controlled Intervention. J Nurs Scholarsh. 2025 Jul;57(4):563-575. doi: 10.1111/jnu.70003. Epub 2025 Feb 24.
Xu H, Liu J, Li P, Liang Y. Effects of mind-body exercise on perimenopausal and postmenopausal women: a systematic review and meta-analysis. Menopause. 2024 May 1;31(5):457-467. doi: 10.1097/GME.0000000000002336.
Lu CB, Liu PF, Zhou YS, Meng FC, Qiao TY, Yang XJ, Li XY, Xue Q, Xu H, Liu Y, Han Y, Zhang Y. Musculoskeletal Pain during the Menopausal Transition: A Systematic Review and Meta-Analysis. Neural Plast. 2020 Nov 25;2020:8842110. doi: 10.1155/2020/8842110. eCollection 2020.
Collins BC, Laakkonen EK, Lowe DA. Aging of the musculoskeletal system: How the loss of estrogen impacts muscle strength. Bone. 2019 Jun;123:137-144. doi: 10.1016/j.bone.2019.03.033. Epub 2019 Mar 28.
Zhang C, Feng X, Zhang X, Chen Y, Kong J, Lou Y. Research progress on the correlation between estrogen and estrogen receptor on postmenopausal sarcopenia. Front Endocrinol (Lausanne). 2024 Nov 21;15:1494972. doi: 10.3389/fendo.2024.1494972. eCollection 2024.
Ambikairajah A, Walsh E, Cherbuin N. A review of menopause nomenclature. Reprod Health. 2022 Jan 31;19(1):29. doi: 10.1186/s12978-022-01336-7.
Santoro N. Perimenopause: From Research to Practice. J Womens Health (Larchmt). 2016 Apr;25(4):332-9. doi: 10.1089/jwh.2015.5556. Epub 2015 Dec 10.
Davis SR, Baber RJ. Treating menopause - MHT and beyond. Nat Rev Endocrinol. 2022 Aug;18(8):490-502. doi: 10.1038/s41574-022-00685-4. Epub 2022 May 27.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KA25/405
Identifier Type: -
Identifier Source: org_study_id